Search

Medtronic PLC

Cerrado

SectorSanidad

96.57 -0.54

Resumen

Variación precio

24h

Actual

Mínimo

96.23

Máximo

97.96

Métricas clave

By Trading Economics

Ingresos

206M

1.5B

Ventas

-51M

9.8B

P/B

Media del Sector

23.463

50.373

BPA

1.45

Rentabilidad por dividendo

2.99

Margen de beneficios

15.16

Empleados

95,000

EBITDA

47M

2.7B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+6.26% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

2.99%

2.12%

Próximas Ganancias

17 nov 2026

Fecha Próximo Dividendo

15 ene 2027

Próxima Fecha de Ex Dividendo

25 dic 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

5.2B

121B

Apertura anterior

97.11

Cierre anterior

96.57

Medtronic PLC Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

29 oct 2026, 23:03 UTC

Medtronic PLC shares are advancing in after-market trading, supported by a strong Health Care Equipment sub-sector performance since Thursday's close.

28 oct 2026, 23:02 UTC

Medtronic PLC shares advanced in after-market hours, reflecting a modest increase since Wednesday's close and remaining near the upper end of its one-month range.

27 oct 2026, 23:01 UTC

Medtronic PLC shares traded modestly lower during after-market hours on Tuesday, marking a decline over four consecutive sessions.

26 oct 2026, 22:41 UTC

Medtronic PLC shares are trading modestly lower in after-market hours.

23 oct 2026, 23:01 UTC

Medtronic PLC shares advanced in after-market trading, supported by a notable rise in the Health Care Equipment sub-sector.

22 oct 2026, 23:41 UTC

Event

Medtronic PLC announced positive real-world registry results for its Affera™ Mapping and Ablation System and Sphere-9™ Catheter, along with the PulseSelect™ PFA System.

21 oct 2026, 20:02 UTC

News

Medtronic PLC shares declined sharply, retracing from an early high and hitting a mid-afternoon low, amid high market volume.

20 oct 2026, 21:03 UTC

Medtronic PLC shares are trading modestly lower in after-market hours, having retraced from a brief high shortly after the market closed.

19 oct 2026, 23:01 UTC

News

Medtronic PLC appointed Michael Marinaro as President, effective October 14, 2026, with a $1M salary and $3.25M in long-term incentives.

16 oct 2026, 20:07 UTC

Medtronic PLC shares are modestly lower, following a broader market decline of nearly three-quarters of a percent since Thursday's close.

15 oct 2026, 20:07 UTC

News

Medtronic PLC completed the separation of MiniMed Group, Inc., exchanging 252.81M shares of MiniMed for 55.03M of its own ordinary shares.

14 oct 2026, 23:01 UTC

Medtronic PLC shares are trading lower in after-market hours, having pulled back from earlier gains, now near the lower end of today’s range.

13 oct 2026, 23:01 UTC

Medtronic PLC shares declined in after-market hours, reversing from earlier gains to a modest loss since Tuesday's close.

12 oct 2026, 22:01 UTC

Medtronic PLC shares are trading modestly lower in after-market hours, having retraced from earlier gains.

9 oct 2026, 21:01 UTC

Medtronic PLC shares are trading modestly higher in after-market hours, following a pullback earlier in the session and three consecutive sessions of gains.

8 oct 2026, 23:05 UTC

Medtronic PLC saw a modest increase in after-market trading, recovering from earlier lows while remaining below its 20-day moving average.

7 oct 2026, 22:51 UTC

News

Medtronic PLC announced an exchange ratio of 4.5939 shares of MiniMed Group, Inc. stock for each ordinary share, contributing to a modest gain in after-market trading.

6 oct 2026, 22:40 UTC

Medtronic PLC is recovering in after-market trading, rising sharply from Tuesday's close and reaching its highest level of the day, despite remaining below its 20-day moving average.

5 oct 2026, 21:01 UTC

Medtronic PLC traded roughly flat during after-market hours, closing near the lower end of its one-month range and below its 20-day moving average.

3 oct 2026, 00:00 UTC

Medtronic PLC shares traded modestly higher in after-market hours on Friday, recovering from a brief dip and remaining near the lower end of their one-month trading range.

2 oct 2026, 23:00 UTC

Medtronic PLC is advancing in after-market trading, showing a modest increase since Friday's close, with significant upward movement shortly after the market reopened.

1 oct 2026, 22:01 UTC

News

Medtronic PLC shares are higher in after-market trading following the approval of new CPT codes for its Altaviva and Symplicity Spyral devices, effective January 2028.

30 sept 2026, 23:01 UTC

Medtronic PLC is trading modestly higher in after-market hours, reflecting broader market trends amid positive economic indicators and stronger-than-expected private sector job growth.

29 sept 2026, 20:02 UTC

Medtronic PLC shares fell sharply today, reversing a trend of higher daily closes, amid unusually high trading volume and broader market trends.

28 sept 2026, 23:16 UTC

Medtronic PLC is trading slightly lower in after-market hours, remaining below its 20-day moving average and near the lower end of its one-month range.

25 sept 2026, 23:50 UTC

Medtronic PLC is down in after-market trading, continuing a seven-session trend of lower finishes and remaining significantly below its 20-day moving average.

23 sept 2026, 20:03 UTC

News

Medtronic PLC shares fell sharply, continuing a downward trend with five consecutive losses, despite solid first-quarter results and raised full-year guidance.

22 sept 2026, 23:21 UTC

Medtronic PLC is trading modestly higher in after-market hours, stabilizing after an initial decline amid broader market weakness.

21 sept 2026, 19:46 UTC

News

Medtronic PLC shares fell as the company raised its adjusted profit forecast and reported revenue growth for Q1 fiscal 2027, despite FDA clearance for its LigaSure device.

18 sept 2026, 23:06 UTC

News

Medtronic PLC raised its fiscal 2027 profit forecast and reported first-quarter revenue of $9.756 billion, exceeding expectations, in after-market trading.

Comparación entre iguales

Cambio de precio

Medtronic PLC previsión

Precio Objetivo

By TipRanks

6.26% repunte

Estimación a 12 Meses

Media 103.188 USD  6.26%

Máximo 118 USD

Mínimo 85 USD

De acuerdo con 19 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Medtronic PLC Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

19 ratings

10

Comprar

9

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.
help-icon Live chat